Polypharmacy during pregnancy and associated risk factors: a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019
Authors:
- Anuradhaa SubramanianASAnuradhaa Subramanian
- Amaya Azcoaga-LorenzoAAAmaya Azcoaga-Lorenzo
- Astha AnandAAAstha Anand
- Katherine PhillipsKPKatherine Phillips
- Siang Ing LeeSLSiang Ing Lee
- Neil CockburnNCNeil Cockburn
- Adeniyi Francis FagbamigbeAFAdeniyi Francis Fagbamigbe
- Christine Damase-MichelCDChristine Damase-Michel
- Christopher YauCYChristopher Yau
- Colin McCowanCMColin McCowan
- Dermot O’rEillyDODermot O’rEilly
- Gillian SantorelliGSGillian Santorelli
Open Access
- 16 January 2023
- journal article
- research article
- Published by Springer Nature in BMC Medicine
- Vol. 21 (1) , 1-13
Abstract
Background: The number of medications prescribed during pregnancy has increased over the past few decades. Few studies have described the prevalence of multiple medication use among pregnant women. This study aims to describe the overall prevalence over the last two decades among all pregnant women and those with multimorbidity and to identify risk factors for polypharmacy in pregnancy. Methods: A retrospective cohort study was conducted between 2000 and 2019 using the Clinical Practice Research Datalink (CPRD) pregnancy register. Prescription records for 577 medication categories were obtained. Prevalence estimates for polypharmacy (ranging from 2+ to 11+ medications) were presented along with the medications commonly prescribed individually and in pairs during the first trimester and the entire pregnancy period. Logistic regression models were performed to identify risk factors for polypharmacy. Results: During the first trimester (812,354 pregnancies), the prevalence of polypharmacy ranged from 24.6% (2+ medications) to 0.1% (11+ medications). During the entire pregnancy period (774,247 pregnancies), the prevalence ranged from 58.7 to 1.4%. Broad-spectrum penicillin (6.6%), compound analgesics (4.5%) and treatment of candidiasis (4.3%) were commonly prescribed. Pairs of medication prescribed to manage different long-term conditions commonly included selective beta 2 agonists or selective serotonin re-uptake inhibitors (SSRIs). Risk factors for being prescribed 2+ medications during the first trimester of pregnancy include being overweight or obese [aOR: 1.16 (1.14–1.18) and 1.55 (1.53–1.57)], belonging to an ethnic minority group [aOR: 2.40 (2.33–2.47), 1.71 (1.65–1.76), 1.41 (1.35–1.47) and 1.39 (1.30–1.49) among women from South Asian, Black, other and mixed ethnicities compared to white women] and smoking or previously smoking [aOR: 1.19 (1.18–1.20) and 1.05 (1.03–1.06)]. Higher and lower age, higher gravidity, increasing number of comorbidities and increasing level of deprivation were also associated with increased odds of polypharmacy. Conclusions: The prevalence of polypharmacy during pregnancy has increased over the past two decades and is particularly high in younger and older women; women with high BMI, smokers and ex-smokers; and women with multimorbidity, higher gravidity and higher levels of deprivation. Well-conducted pharmaco-epidemiological research is needed to understand the effects of multiple medication use on the developing foetus.Keywords
Funding Information
- Medical Research Council (MR/W014432/1)
This publication has 41 references indexed in Scilit:
- Multimorbidity, polypharmacy, referrals, and adverse drug events: are we doing things well?British Journal of General Practice, 2012
- Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional studyThe Lancet, 2012
- Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008American Journal of Obstetrics and Gynecology, 2011
- Drug use during pregnancy in Sweden – assessed by the Prescribed Drug Register and the Medical Birth RegisterClinical Epidemiology, 2011
- Adverse drug events in the outpatient setting: an 11‐year national analysisPharmacoepidemiology and Drug Safety, 2010
- Medication use in early pregnancy‐prevalence and determinants of use in a prospective cohort of womenPharmacoepidemiology and Drug Safety, 2010
- Prescription drug use among fathers and mothers before and during pregnancy. A population‐based cohort study of 106 000 pregnancies in Norway 2004–2006British Journal of Clinical Pharmacology, 2008
- Safety of medications prescribed before and during early pregnancy in a cohort of 81 975 mothers from the UK General Practice Research DatabasePharmacoepidemiology and Drug Safety, 2006
- Prescription drug use in pregnancyAmerican Journal of Obstetrics and Gynecology, 2004
- What are the Read Codes?Health Libraries Review, 1994